Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L1NF
|
||||
Former ID |
DIB007824
|
||||
Drug Name |
D-420720
|
||||
Synonyms |
Dipeptidyl peptidase inhibitor (diabetes), Development Centre for Biotechnology
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Investigative | [543447] | ||
Company |
Development Centre for Biotechnology
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C(#N)[C@@H]1CCCN1C(=O)CNCCNS(=O)(=O)c1ccc(cc1)F
|
||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [543447] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.